Biosenta Inc. ZRO
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 101.86% | 300.00% | 0.00% | 100.00% | -199.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 101.86% | 300.00% | 0.00% | 100.00% | -199.05% |
| Cost of Revenue | 260.00% | 280.00% | -20.00% | -20.00% | 0.00% |
| Gross Profit | 100.62% | 150.00% | -25.00% | 33.33% | -199.45% |
| SG&A Expenses | 19.98% | 0.09% | 12.52% | 9.74% | -4.37% |
| Depreciation & Amortization | -11.11% | -15.79% | -40.74% | -22.73% | 5.88% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.03% | 0.68% | 11.65% | 8.48% | -8.19% |
| Operating Income | -2.67% | -0.48% | -11.72% | -8.46% | -28.98% |
| Income Before Tax | -0.92% | 5.91% | -5.13% | -9.38% | 63.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.92% | 5.91% | -5.13% | -9.38% | 63.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.92% | 5.91% | -5.13% | -9.38% | 63.06% |
| EBIT | -2.67% | -0.48% | -11.72% | -8.46% | -28.98% |
| EBITDA | -2.71% | -0.52% | -11.77% | -39.97% | -258.04% |
| EPS Basic | -29.38% | 11.11% | 4.77% | 5.28% | 62.43% |
| Normalized Basic EPS | -29.10% | 11.36% | 5.07% | 5.34% | -13.83% |
| EPS Diluted | -29.38% | 11.11% | 4.77% | 5.28% | 62.43% |
| Normalized Diluted EPS | -29.10% | 11.36% | 5.07% | 5.34% | -13.83% |
| Average Basic Shares Outstanding | -11.03% | 5.75% | 10.64% | 16.10% | 10.94% |
| Average Diluted Shares Outstanding | -11.03% | 5.75% | 10.64% | 16.10% | 10.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |